Ignite Creation Date:
2025-12-24 @ 5:55 PM
Ignite Modification Date:
2026-01-02 @ 9:44 AM
Study NCT ID:
NCT01199068
Status:
COMPLETED
Last Update Posted:
2021-05-13
First Post:
2010-08-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)
Sponsor:
Daiichi Sankyo Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06
Start Date Type:
None
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-12
Completion Date Type:
ACTUAL
First Submit Date:
2010-08-30
First Submit QC Date:
None
Study First Post Date:
2010-09-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-04
Results First Submit QC Date:
None
Results First Post Date:
2020-07-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-16
Last Update Post Date:
2021-05-13
Last Update Post Date Type:
ACTUAL